Currently the Director of Higher Degrees by Research at RMIT, Professor Gorry holds an honorary appointment at Burnet.
He is still the Head of the HIV Molecular Pathogenesis Laboratory based at Burnet Institute. A molecular virologist, his research interests include determining how HIV enters cells of the immune system, how HIV evolves in patients to become more capable of destroying cells of the immune system, how HIV escapes the effects of antiviral drugs that target virus entry, and developing new laboratory tests to help physicians better manage their patients.
Professor Gorry completed his PhD in 1998 before undertaking postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, USA between 1999 and 2002. On his return to Melbourne in 2002 he established his laboratory at the Burnet Institute where he is a Burnet Principal Fellow.
He holds adjunct appointments as Professor, Department of Infectious Diseases, Monash University, Associate Professor in the Department of Medicine at Monash University, Associate Professor in the Department of Microbiology and Immunology at the University of Melbourne, and Associate Professor in the School of Applied Sciences at RMIT University.
- 2015: Director of Higher Degrees by Research at RMIT University, Melbourne
- 2013: Deputy Head, Centre for Biomedical Research
- 2012: Adjunct Professor, Department of Infectious Diseases, Monash University
- 2011: Adjunct Associate Professor of Applied Science, RMIT University
- 2008: Adjunct Associate Professor of Microbiology and Immunology, University of Melbourne
- 2007: Chair, National Centre for HIV Epidemiology and Clinical Research Neurology Working Group
- 2007: Adjunct Associate Professor of Medicine, Monash University, Victoria, Australia
- 2007: Burnet Principal Fellow, Centre for Virology, Victoria, Australia
- 2004: Co-coordinator, Burnet Institute Honours Degree program,Australia
- 2002: Head, HIV Molecular Pathogenesis Laboratory, Burnet Institute, Australia
- 1999-2002: Research Fellow, department of Pathology, Harvard Medical School, Boston, USA
- 1999-2002: Postdoctoral Fellow, department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, USA
- 1998: PhD, Royal Melbourne Institute Technology and the Macfarlane Burnet Centre for Medical Research, Victoria, Australia
- 1994: BAppSci, Royal Melbourne Institute Technology, Australia
- 2012: ARC (Australian Research Council) Future Fellowship
- 2011: Gust-McKenzie Medallist
- 2009: National Health and Medical Research Council Level 2 Biomedical Career - Development Award
- 2008: Associate Member, Faculty of 1000 Medicine
- 2008: Victorian Young Tall Poppy Science Award
- 2005: National Health and Medical Research Council R. Douglas Wright Biomedical Career Development Award
- Analysis of clinical HIV-1 strains with resistance to maraviroc reveals strain-specific resistance mutations, variable degrees of resistance, and minimal cross-resistance to other CCR5 antagonists.
Flynn J, Ellenberg P, Duncan R, Ellett A, Zhou J, Sterjovski J, Cashin K, Borm K, Gray L, Lewis M, Jubb B, Westby M, Lee B, Lewin SR, Churchill M, Roche M, Gorry P
AIDS Res Hum Retroviruses. 2017 Aug; 33(12):1220-1235
- HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells.
Xu Y, Phetsouphanh C, Suzuki K, Aggrawal A, Graff-Dubois S, Roche M, Bailey M, Alcantara S, Cashin K, Sivasubramaniam R, Koelsch KK, Autran B, Harvey R, Gorry PR, Moris A, Cooper DA, Turville S, Kent SJ, Kelleher AD, Zaunders J
Front Immunol. 2017 Apr; 8:376
News Articles (13)